share_log

Short Interest in European Biotech Acquisition Corp. (NASDAQ:EBAC) Rises By 2,112.5%

Short Interest in European Biotech Acquisition Corp. (NASDAQ:EBAC) Rises By 2,112.5%

歐洲生物科技收購公司 (NASDAQ: EBAC) 短期權益上升 2,112.5%
Financial News Live ·  2022/10/12 10:51

European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) saw a large increase in short interest in September. As of September 30th, there was short interest totalling 17,700 shares, an increase of 2,112.5% from the September 15th total of 800 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average trading volume of 18,500 shares, the short-interest ratio is presently 1.0 days.

歐洲生物技術收購公司（NASDAQ：EBAC-獲得評級）9 月份短期利息大幅增加。截至 9 月 30 日，總共有 17,700 股的短期利息，較 9 月 15 日共 800 股股份增加了 2,112.5%。大約 0.1％ 的股票賣空。根據 18,500 股的平均交易量，短息比率目前為 1.0 天。

European Biotech Acquisition Stock Performance

歐洲生物科技收購股票表

NASDAQ EBAC remained flat at $9.92 during trading hours on Wednesday. 106 shares of the company traded hands, compared to its average volume of 30,028. European Biotech Acquisition has a one year low of $9.66 and a one year high of $10.50. The stock's 50-day moving average price is $9.89.

納斯達克 EBAC 在周三的交易時間內保持平穩 9.92 美元。該公司的 106 股股份交易手，相比其平均交易量為 30,028。歐洲生物技術收購有一年低點 9.66 美元，一年新高為 10.50 美元。該股票的 50 天移動平均價為 9.89 美元。

Get
取得
European Biotech Acquisition
歐洲生技收購
alerts:
警報：

Institutional Trading of European Biotech Acquisition

歐洲生物科技收購機構交易

A hedge fund recently raised its stake in European Biotech Acquisition stock. Cubist Systematic Strategies LLC raised its position in European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) by 136.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 60,555 shares of the company's stock after purchasing an additional 34,896 shares during the quarter. Cubist Systematic Strategies LLC's holdings in European Biotech Acquisition were worth $593,000 as of its most recent SEC filing.

對沖基金最近增加了對歐洲生物技術收購股份的股份。立體派系統策略有限責任公司在歐洲生物技術收購公司（NASDAQ：EBAC-獲得評級）在第二季度提高了 136.0％ 的地位，根據其最近向證券交易委員會（SEC）提出的文件。該基金在本季度額外購買 34,896 股股票後擁有該公司股票 60,555 股。立體派系統策略有限責任公司在歐洲生物技術收購的持有價值 593,000 美元作為其最近的 SEC 備案.

European Biotech Acquisition Company Profile

歐洲生物科技收購公司簡

(Get Rating)
(取得評分)

European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.

歐洲生物技術收購公司沒有重大業務。該公司打算與一個或多個企業或實體進行合併，股票交換，資產購買，股票購買，重組或類似的業務合併。歐洲生物技術收購公司成立於 2021 年，總部位於荷蘭阿姆斯特丹。

Read More

閱讀更多

  • Get a free copy of the StockNews.com research report on European Biotech Acquisition (EBAC)
  • Institutional Investors Are Buying These Two Stocks
  • Put Pep In Your Portfolio With Low-Beta Pepsico
  • Is Take-Two Interactive Software Inc. a Q4 Winner?
  • 3 Oil Stocks That Are Heating Back Up
  • Why All the Buzz Around These 3 Stocks?
  • 獲取有關歐洲生物技術收購研究報告的免費副本
  • 機構投資者正在購買這兩隻股票
  • 把 PEP 在你的投資組合與低 β 百事可樂
  • 是採取兩個互動軟件公司. Q4 贏家?
  • 3 正在升溫的石油庫存
  • 為什麼所有的嗡嗡聲圍繞這些 3 股票?

Receive News & Ratings for European Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for European Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

接收歐洲生物技術收購日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收歐洲生物技術收購及相關公司的最新新聞和分析師評級的簡要每日摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論